Özgür Kurt | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Özgür Kurt | Medicine and Dentistry | Best Researcher Award

M.D. Ph.D. at ACIBADEM UNIVERSITY, Turkey

Prof. Dr. Özgür Kurt is a distinguished Professor of Medical Microbiology at Acibadem University, Turkey, with extensive expertise in parasitology and tropical diseases. He holds both an M.D. and a Ph.D. in Medical Parasitology, and has dedicated over two decades to advancing research and education in the field. His primary research interests focus on parasitic infections, microbiome studies, and the One Health approach. Dr. Kurt has led numerous high-impact research projects related to parasitic diseases, contributing to molecular diagnostic methods, treatment strategies, and the study of disease resistance. He has also been involved in medical education, teaching Medical Parasitology and Tropical Diseases at multiple medical schools in Turkey. In addition to his academic achievements, Dr. Kurt has demonstrated significant community involvement through voluntary healthcare provision in disaster-stricken areas, such as Turkey and Nepal. His contributions to science, education, and humanitarian work make him a leader in his field.

Professional Profile 

Education

Prof. Dr. Özgür Kurt’s academic journey reflects a strong foundation in medicine and parasitology. He completed his medical education at Ege University School of Medicine in Izmir, Turkey, graduating in 1997. Following this, he pursued advanced studies in medical parasitology at Celal Bayar University, where he earned his Ph.D. in 2006. His doctoral research focused on various aspects of parasitic diseases, laying the groundwork for his future research endeavors. Over the years, Dr. Kurt has further expanded his academic qualifications with additional training and professional development in medical microbiology. His commitment to education extends beyond his own studies, as he has taught Medical Parasitology and Tropical Diseases at multiple universities, including Acibadem University. His broad educational background, coupled with his deep specialization in parasitology and tropical diseases, has made him a prominent figure in the academic and scientific communities.

Professional Experience  

Prof. Dr. Özgür Kurt has a distinguished career in both clinical and academic settings. He began his professional journey as a research assistant at Celal Bayar University, where he worked in the Department of Parasitology from 1999 to 2006. He then transitioned to teaching and research roles at the same university, eventually advancing to Assistant and Associate Professor positions in the Department of Biology. In 2013, Dr. Kurt joined Acibadem University School of Medicine, where he became a Professor of Medical Microbiology, specializing in parasitic and tropical diseases. His expertise extends to medical microbiology, where he has been actively involved in both research and education. Dr. Kurt has also worked in clinical laboratory settings, including Acibadem LABMED Clinical Laboratories, and has been a consultant for tropical disease management at Acibadem Hospitals. Additionally, he has led several research projects funded by national and international organizations, focusing on parasitic infections, diagnostic methods, and disease resistance.

Research Interest

Prof. Dr. Özgür Kurt’s research interests focus on parasitic and tropical diseases, with a particular emphasis on their impact in the context of One Health. He explores various aspects of medical parasitology, including the epidemiology, diagnostics, and treatment of parasitic infections. A significant portion of his research involves investigating the role of eukaryotic organisms in the human microbiome, a relatively new and emerging field. Dr. Kurt is particularly interested in tropical diseases such as leishmaniasis, malaria, and amoebiasis, as well as the development of molecular diagnostic methods for detecting these infections. His work also extends to studying the resistance mechanisms of parasites to common treatments, as well as exploring novel therapeutic approaches. Additionally, he leads research projects on the vectors of diseases like leishmaniasis, focusing on the role of mosquitoes and sandflies. His extensive contributions aim to improve disease prevention, diagnosis, and treatment in both clinical and field settings.

Award and Honor

Prof. Dr. Özgür Kurt has received various awards and honors throughout his distinguished career, recognizing his significant contributions to the field of medical microbiology and parasitology. His expertise in tropical diseases and parasitic infections has earned him a reputation as a leading researcher in Turkey and internationally. Dr. Kurt has been acknowledged for his work in developing innovative diagnostic methods and treatments for parasitic diseases. He has received funding for numerous research projects from prestigious organizations, such as TÜBİTAK, and his research has been widely published in respected journals. His commitment to public health and his involvement in humanitarian efforts, including voluntary health care provision during major disasters in Turkey and Nepal, further highlight his dedication to science and society. Dr. Kurt’s ongoing contributions to medical education, clinical practice, and research continue to inspire future generations of scientists and healthcare professionals.

Conclusion

Dr. Özgür Kurt is a highly deserving candidate for the Best Researcher Award. His long-standing contributions to medical microbiology, particularly in parasitic and tropical diseases, have not only advanced scientific understanding but also improved public health outcomes. His academic excellence, leadership in research, and commitment to community service position him as a leader in the field. Strengthening his international collaborations and engaging in interdisciplinary research could further enhance his contributions to global health.

Publications Top Noted
  • Title: A possible link between subtype 2 and asymptomatic infections of Blastocystis hominis
    Authors: F Dogruman-Al, H Dagci, H Yoshikawa, Ö Kurt, M Demirel
    Year: 2008
    Citations: 168
  • Title: Molecular epidemiology of Blastocystis infections in Turkey
    Authors: M Özyurt, Ö Kurt, K Mølbak, HV Nielsen, T Haznedaroglu, CR Stensvold
    Year: 2008
    Citations: 165
  • Title: Toxoplasmosis in transplant recipients, Europe, 2010–2014
    Authors: F Robert-Gangneux, V Meroni, D Dupont, F Botterel, JMA Garcia, …
    Year: 2018
    Citations: 134
  • Title: Eradication of Blastocystis in humans: Really necessary for all?
    Authors: Ö Kurt, FD Al, M Tanyüksel
    Year: 2016
    Citations: 102
  • Title: Epidemiological and diagnostic features of Blastocystis infection in symptomatic patients in Izmir province, Turkey
    Authors: H Dagci, K Özgür, M Demirel, A Mandiracioglu, S Aydemir, SAZ Ulas, …
    Year: 2014
    Citations: 101
  • Title: Serological levels of zinc, copper and iron elements among Giardia lamblia infected children in Turkey
    Authors: P Ertan, K Yereli, Ö Kurt, IC BalcioĞlu, A OnaĞ
    Year: 2002
    Citations: 94
  • Title: Rural life, lower socioeconomic status and parasitic infections
    Authors: IC Balcioglu, Ö Kurt, ME Limoncu, G Dinç, M Gümüş, AA Kilimcioglu, …
    Year: 2007
    Citations: 83
  • Title: A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis
    Authors: Ö Kurt, N Girginkardeşler, IC Balcioğlu, A Özbilgin, ÜZ Ok
    Year: 2008
    Citations: 80
  • Title: Preliminary virtual screening studies to identify GRP78 inhibitors which may interfere with SARS-CoV-2 infection
    Authors: A Palmeira, E Sousa, A Köseler, R Sabirli, T Gören, I Türkçüer, Ö Kurt, …
    Year: 2020
    Citations: 76
  • Title: Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey
    Authors: A Özbilgin, M Harman, M Karakuş, A Bart, S Töz, Ö Kurt, İ Çavuş, E Polat, …
    Year: 2017
    Citations: 75
  • Title: Endoplasmic reticulum stress markers in SARS-COV-2 infection and pneumonia: case-control study
    Authors: A Köseler, R Sabirli, T Gören, İ Türkçüer, Ö Kurt
    Year: 2020
    Citations: 69
  • Title: Leishmaniasis in Turkey: first clinical isolation of Leishmania major from 18 autochthonous cases of cutaneous leishmaniasis in four geographical regions
    Authors: A Özbilgin, G Çulha, S Uzun, M Harman, SG Topal, F Okudan, F Zeyrek, …
    Year: 2016
    Citations: 68

Jennifer Lin | Health Science | Best Researcher Award

Posted on by ScienceFather

Dr. Jennifer Lin | Health Science | Best Researcher Award

Health and Economic Outcome Researcher at Pacira, United States

Jennifer Hsiang-Ling Lin is an accomplished researcher with extensive experience in population health sciences, focusing on disease etiology, precision and translational medicine, causal inference, patient outcomes, and treatment efficacy. She has contributed significantly to the fields of orthopedics, chronic pain, oncology, cardiovascular disease, and more. Her work spans across pre-launch product activities, phase II and III trials, and post-launch product value evidence generation. Jennifer has a strong background in analytics, with hands-on experience in working with primary and secondary research databases across various regions. She has published numerous high-impact medical papers and served as an editorial reviewer for prestigious journals. Her leadership in mentoring and developing clinical fellows and junior researchers further highlights her commitment to advancing the field of health sciences. 🌟

Professional profile
Education🎓

Jennifer earned her academic credentials with distinction, holding a position as an Assistant Professor at Brigham and Women’s Hospital, Harvard Medical School. During her tenure, she engaged deeply in research activities, focusing on precision medicine, disease prevention, and translational medicine. Her work at Harvard included investigating the etiological factors underlying various diseases and applying her findings to improve prevention strategies. 🎓

Professional Experience🏛️

Jennifer’s career is marked by significant roles in both academia and the pharmaceutical industry. She currently serves as the Senior Director of Epidemiology & Health Outcome Value Assessment at Pacira Biosciences Inc., where she translates business initiatives into real-world research studies. Her prior roles include Director of Analytics at Janssen Scientific Affairs and various leadership positions at Takeda Pharmaceutical Company. Throughout her career, Jennifer has led numerous studies, managed analytical teams, and contributed to critical scientific reviews, all while collaborating with leading academic investigators and data vendors. 📊

Research Interest 💻📚

Jennifer’s research interests are diverse and impactful. She focuses on understanding disease etiology, patient outcomes, and treatment efficacy across various therapeutic areas, including orthopedics, chronic pain, oncology, cardiovascular disease, and more. Her work in precision medicine, translational medicine, and causal inference has advanced the field, providing valuable insights into real-world patient care. She is particularly interested in leveraging big data and advanced statistical modeling to inform clinical trials and improve health outcomes. 🔬

Achievements🏅
  • 🌍 Global Impact: Contributed to over 200 epidemiology/real-world evidence studies across the globe, influencing healthcare practices in the US, Europe, and Asia.
  • 📚 Prolific Author: Published 80+ high-impact medical papers, contributing valuable knowledge to the fields of disease etiology, patient outcomes, and treatment efficacy.
  • 🏆 Leadership in Research: Successfully led multiple cross-functional teams in the pharmaceutical industry, translating business initiatives into impactful research studies.
  • 🎓 Academic Contributions: Held a prestigious academic position as an Assistant Professor at Harvard Medical School, leading research in precision medicine and disease prevention.
  • 🌟 Editorial Excellence: Served as an editorial reviewer for top-tier journals, ensuring the dissemination of high-quality research in the scientific community.
  • 💡 Innovative Projects: Spearheaded numerous innovative research projects in orthopedics, chronic pain, oncology, and cardiovascular disease, advancing understanding in these critical areas.
  • 👩‍🏫 Mentorship: Actively mentored and developed clinical fellows and junior researchers, fostering the next generation of leaders in health sciences.
  • 🏅 Recognition: Recognized for excellence in research and leadership, receiving accolades and awards throughout her career in academia and industry.

Publications top noted📜

  • Endogenous Sex Hormones and Colorectal Cancer Survival Among Men and Women
    • 🖋 Authors: Yang, W., Giovannucci, E.L., Hankinson, S.E., Lin, J.H., Zhang, X.
    • 📅 Year: 2020
    • 📚 Citations: 20
    • 📖 Journal: International Journal of Cancer, 147(4), pp. 920–930.
  • Plasma Estradiol and Testosterone Levels and Ischemic Stroke in Postmenopausal Women
    • 🖋 Authors: Hu, J., Lin, J.H., Jiménez, M.C., Hankinson, S.E., Rexrode, K.M.
    • 📅 Year: 2020
    • 📚 Citations: 12
    • 📖 Journal: Stroke, 51(4), pp. 1297–1300.
  • Interaction between Nonsteroidal Anti-inflammatory Drugs and Low-fat Dietary Intervention on Colorectal Cancer Incidence; the Women’s Health Initiative (WHI) Dietary Modification Trial
    • 🖋 Authors: Kato, I., Lane, D., Womack, C.R., Beebe Dimmer, J., Simon, M.S.
    • 📅 Year: 2017
    • 📚 Citations: 3
    • 📖 Journal: Journal of the American College of Nutrition, 36(6), pp. 462–469.
  • Characteristics of Patients Potentially Eligible for Pharmacotherapy for Weight Loss in Primary Care Practice in the United States
    • 🖋 Authors: Zhang, S., Manne, S., Lin, J., Yang, J.
    • 📅 Year: 2016
    • 📚 Citations: 20
    • 📖 Journal: Obesity Science and Practice, 2(2), pp. 104–114.
  • Lipid Biomarkers and Long-term Risk of Cancer in the Women’s Health Study
    • 🖋 Authors: Chandler, P.D., Song, Y., Lin, J., Buring, J.E., Wang, L.
    • 📅 Year: 2016
    • 📚 Citations: 117
    • 📖 Journal: American Journal of Clinical Nutrition, 103(6), pp. 1397–1407.
  • CYP24A1 Variant Modifies the Association between Use of Oestrogen Plus Progestogen Therapy and Colorectal Cancer Risk
    • 🖋 Authors: Garcia-Albeniz, X., Rudolph, A., Hutter, C., Peters, U., Chang-Claude, J.
    • 📅 Year: 2016
    • 📚 Citations: 20
    • 📖 Journal: British Journal of Cancer, 114(2), pp. 221–229.
  • Habitual Intake of Flavonoid Subclasses and Risk of Colorectal Cancer in 2 Large Prospective Cohorts
    • 🖋 Authors: Nimptsch, K., Zhang, X., Cassidy, A., Giovannucci, E.L., Wu, K.
    • 📅 Year: 2016
    • 📚 Citations: 75
    • 📖 Journal: American Journal of Clinical Nutrition, 103(1), pp. 184–191.
  • Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women
    • 🖋 Authors: Chandler, P.D., Buring, J.E., Manson, J.E., Lee, I.-M., Lin, J.H.
    • 📅 Year: 2015
    • 📚 Citations: 55
    • 📖 Journal: Cancer Prevention Research, 8(8), pp. 675–682.
  • Association between Plasma Adiponectin Levels and Colorectal Cancer Risk in Women
    • 🖋 Authors: Chandler, P.D., Buring, J.E., Manson, J.A.E., Lee, I.-M., Lin, J.H.
    • 📅 Year: 2015
    • 📚 Citations: 12
    • 📖 Journal: Cancer Causes and Control, 26(7), pp. 1047–1052.
  • Environmental Exposure and Tumor Heterogeneity in Colorectal Cancer Risk and Outcomes
    • 🖋 Authors: Lin, J.H., Giovannucci, E.
    • 📅 Year: 2014
    • 📚 Citations: 13
    • 📖 Journal: Current Colorectal Cancer Reports, 10(1), pp. 94–104.